文献速递肾小球疾病

IgA血管炎伴肾炎患者中特异性针对半乳糖缺陷型IgA1的自身抗体

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
PubMed 文献 · Kidney Int Rep · 2019-08-30

该研究通过EBV永生化技术从IgA血管炎伴肾炎(IgAV-N)、IgA血管炎无肾炎(IgAV-woN)、IgA肾病(IgAN)患者及健康对照者中制备IgA1和IgG分泌细胞系,分析Gd-IgA1及其特异性IgG自身抗体。结果发现IgAV-N患者类似IgAN患者,其IgA1分泌细胞产生更多Gd-IgA1,血清Gd-IgA1水平升高,O-糖基化相关基因表达改变,且血清和细胞上清中Gd-IgA1特异性IgG水平升高,活动性疾病患者该抗体水平更高。结论支持IgAV-N与IgAN共享致病特征。

要点

  • IgAV-N患者Gd-IgA1产生增加且血清水平升高,类似IgAN。
  • IgAV-N患者Gd-IgA1特异性IgG自身抗体水平升高,活动期更高。
  • IgAV-N与IgAN可能共享致病机制,提示潜在治疗靶点。

核心结论

  • IgAV-N患者血清和细胞产生的Gd-IgA1及Gd-IgA1特异性IgG自身抗体水平升高,支持IgAV-N与IgAN共享致病特征的假说。

研究设计与样本

  • 研究从EBV永生化细胞系生成IgA1和IgG分泌细胞,来源包括IgAV-woN、IgAV-N、IgAN患者及健康个体,分析血清和细胞培养上清中的Gd-IgA1及特异性IgG自身抗体。

主要发现

  • IgAV-N患者IgA1分泌细胞产生的Gd-IgA1高于IgAV-woN或健康对照,与血清Gd-IgA1水平升高一致。
  • IgAV-N患者IgA1分泌细胞O-糖基化相关基因表达改变:C1GALT1和COSMC降低,ST6GALNAC2升高。
  • IgAV-N与IgAN患者血清和IgG分泌细胞上清中Gd-IgA1特异性IgG水平相似,均高于IgAV-woN或健康对照。
  • 活动性疾病(血尿和明显蛋白尿)的IgAV-N患者血清Gd-IgA1特异性IgG自身抗体水平高于非活动性疾病患者。

临床怎么用

  • Gd-IgA1及其特异性IgG自身抗体可能作为IgAV-N疾病活动性的生物标志物。
  • 针对Gd-IgA1产生或免疫复合物形成的治疗策略可能对IgAV-N和IgAN均有效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with IgA nephropathy (IgAN) have elevated serum levels of galactose-deficient IgA1 (Gd-IgA1) that are bound by Gd-IgA1-specific autoantibodies in pathogenic immune complexes. Renal biopsy histopathologic features of IgA vasculitis (IgAV) with nephritis (IgAV-N) are similar to those of IgAN. Mucosal infections often are associated with clinical onset and exacerbation in both diseases. We investigated whether patients with IgAV-N share pathogenic characteristics of IgAN. METHODS: We generated IgA1- and IgG-secreting cell lines from Epstein-Barr virus (EBV)-immortalized cells of patients with IgAV without nephritis (IgAV-woN), IgAV-N, and IgAN and from healthy individuals. Sera and cell-culture supernatants were used for analysis of Gd-IgA1 and Gd-IgA1-specific IgG autoantibodies. RESULTS: IgA1-producing cells from patients with IgAV-N, like cells from patients with IgAN, secreted more Gd-IgA1 than did cells from patients with IgAV-woN or healthy control subjects, in agreement with elevated serum Gd-IgA1 levels in patients with IgAV-N and IgAN. IgA1-producing cells from patients with IgAV-N had altered expression of genes involved in O-glycan biosynthesis: decreased for core 1 synthase (glycoprotein-N-acetylgalactosamine 3-β-galactosyltransferase 1; C1GALT1) and C1GALT1 Specific Chaperone 1 (C1GALTC1; COSMC) and elevated for N-acetylgalactosaminide α-2,6-sialyltransferase 2 (ST6GALNAC2). Levels of Gd-IgA1-specific IgG in sera and supernatants of IgG-producing cells were similar for patients with IgAV-N and IgAN and higher than those for IgAV-woN patients or healthy control subjects. Moreover, patients with IgAV-N who had active disease, manifested by hematuria and substantial proteinuria, had higher serum levels of Gd-IgA1-specific IgG autoantibodies than did patients with IgAV-N who had inactive disease. CONCLUSION: Serum levels and cellular production of Gd-IgA1 and Gd-IgA1-specific IgG autoantibodies were elevated in patients with IgAV-N, supporting the hypothesis that IgAV-N and IgAN share pathogenic features.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Suzuki H, Moldoveanu Z, Julian BA, et al. Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis. Kidney Int Rep. 2019. PMID: 31844808. doi:10.1016/j.ekir.2019.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。